Concurrent validity, cut-offs and ability to change of patient-reported outcome measures for rhinitis and asthma in MASK-air®

dc.contributor.authorBousquet, J
dc.contributor.authorSousa-Pinto, B
dc.contributor.authorAnto, JM
dc.contributor.authorBedbrook, A
dc.contributor.authorCzarlewski, W
dc.contributor.authorAnsotegui, IJ
dc.contributor.authorBergmann, KC
dc.contributor.authorBraido, F
dc.contributor.authorBrussino, L
dc.contributor.authorCecchi, L
dc.contributor.authorLoureiro, CC
dc.contributor.authorCruz, AA
dc.contributor.authorDevillier, P
dc.contributor.authorFiocchi, A
dc.contributor.authorGemicioglu, B
dc.contributor.authorHaahtela, T
dc.contributor.authorIvancevich, JC
dc.contributor.authorKlimek, L
dc.contributor.authorKulus, M
dc.contributor.authorKuna, P
dc.contributor.authorKupczyk, M
dc.contributor.authorKvedariene, V
dc.contributor.authorLarenas-Linnemann, DE
dc.contributor.authorLouis, G
dc.contributor.authorLouis, R
dc.contributor.authorMakris, M
dc.contributor.authorMorais-Almeida, M
dc.contributor.authorNiedoszytko, M
dc.contributor.authorOhta, K
dc.contributor.authorOllert, M
dc.contributor.authorPapadopoulos, N
dc.contributor.authorPatella, V
dc.contributor.authorPétré, B
dc.contributor.authorPfaar, O
dc.contributor.authorPuggioni, F
dc.contributor.authorQuirce, S
dc.contributor.authorRegateiro, FS
dc.contributor.authorRoche, N
dc.contributor.authorRouadi, PW
dc.contributor.authorSamolinski, B
dc.contributor.authorSastre, J
dc.contributor.authorSchleich, F
dc.contributor.authorScichilone, N
dc.contributor.authorTaborda-Barata, L
dc.contributor.authorToppila-Salmi, S
dc.contributor.authorValiulis, A
dc.contributor.authorKoyuncu, IV
dc.contributor.authorVentura, MT
dc.contributor.authorYorgancioglu, A
dc.contributor.authorFonseca, JA
dc.contributor.authorZuberbier, T
dc.date.accessioned2025-04-10T10:38:01Z
dc.date.available2025-04-10T10:38:01Z
dc.description.abstractPatient-reported outcome measures (PROMs) are used to assess a patient's health status at a particular point in time. They are essential in the development of person-centred care. This paper reviews studies performed on PROMs for assessing AR and asthma control, in particular VAS scales that are included in the app MASK-air (R) (Mobile Airways Sentinel networK) for asthma and rhinitis. VASs were initially developed on paper and pencil and tested for their criterion validity, cut-offs and responsiveness. Then, a multicentric, multinational, double-blind, placebo-controlled, randomised control trial (DB-PC-RCT) using an electronic VAS form was carried out. Finally, with the development of MASK-air (R) in 2015, previously validated VAS questions were adapted to the digital format and further methodologic evaluations were performed. VAS for asthma, rhinitis, conjunctivitis, work and EQ-5D are included in the app. Additionally, two control-medication scores for allergic symptoms of asthma (e-DASTHMA) were validated for their criterion validity, cut-offs and responsiveness.
dc.identifier.e-issn2045-7022
dc.identifier.urihttp://hdl.handle.net/20.500.14701/43292
dc.language.isoEnglish
dc.titleConcurrent validity, cut-offs and ability to change of patient-reported outcome measures for rhinitis and asthma in MASK-air®
dc.typeArticle

Files